See the DrugPatentWatch profile for cosentyx

The mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna, have undergone extensive clinical trials and have been shown to be safe and effective in preventing COVID-19 [1]. However, there is limited data on the interaction between mRNA vaccines and specific immunosuppressive treatments, such as Cosentyx (secukinumab) [2].

Cosentyx is a medication used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis [3]. It works by blocking the action of a specific protein involved in the body's immune response, which can help reduce inflammation and alleviate symptoms of these conditions [3].

According to DrugPatentWatch.com, there are currently no known drug-drug interactions between mRNA vaccines and Cosentyx [4]. However, it is important to note that individuals taking immunosuppressive medications, such as Cosentyx, may have a reduced immune response to vaccines, including mRNA vaccines [2].

Therefore, it is recommended that individuals taking Cosentyx or other immunosuppressive medications consult with their healthcare provider before receiving an mRNA vaccine [2]. Healthcare providers may consider monitoring the patient's immune response to the vaccine and adjusting their treatment plan as necessary [2].

In summary, while there are currently no known drug-drug interactions between mRNA vaccines and Cosentyx, individuals taking immunosuppressive medications may have a reduced immune response to vaccines. It is important for these individuals to consult with their healthcare provider before receiving an mRNA vaccine.

Sources:

1. "mRNA and COVID-19 Vaccines." Centers for Disease Control and Prevention, 2021, [www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html](http://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html).
2. "COVID-19 Vaccines for People Who Are Immunocompromised or Taking Medications That Weaken the Immune System." U.S. Food and Drug Administration, 2021, [www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines-people-who-are-immunocompromised-or-taking-medications-weaken-immune](http://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines-people-who-are-immunocompromised-or-taking-medications-weaken-immune).
3. "Cosentyx." Novartis Pharmaceuticals Corporation, 2021, [www.cosentyx.com/](http://www.cosentyx.com/).
4. "Secukinumab (Cosentyx) Drug Interactions." DrugPatentWatch.com, 2021, [www.drugpatentwatch.com/drugs/secukinumab](http://www.drugpatentwatch.com/drugs/secukinumab).